{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:47:33Z","timestamp":1782089253237,"version":"3.54.5"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":58,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-50190-1","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:56:45Z","timestamp":1777125405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["von Willebrand Factor fibers formed at pathological high shear provide a scaffold for \u03b1-synuclein binding and aggregation"],"prefix":"10.1038","volume":"16","author":[{"given":"Jason M.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"50190_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1756-8722-5-65","volume":"5","author":"H Yuan","year":"2012","unstructured":"Yuan, H. et al. The unfolded von Willebrand factor response in bloodstream: the self-association perspective. J. Hematol. Oncol. 5, 65 (2012).","journal-title":"J. Hematol. Oncol."},{"key":"50190_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1161\/ATVBAHA.112.300522","volume":"33","author":"TV Colace","year":"2013","unstructured":"Colace, T. V. & Diamond, S. L. Direct observation of von Willebrand Factor elongation and fiber formation on collagen during acute whole blood exposure to pathological flow. ATVB 33, 105\u2013113 (2013).","journal-title":"ATVB"},{"key":"50190_CR3","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/jth.13044","volume":"13","author":"BA Herbig","year":"2015","unstructured":"Herbig, B. A. & Diamond, S. L. Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation. J. Thromb. Haemost. 13, 1699\u20131708 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"50190_CR4","doi-asserted-by":"publisher","first-page":"H73","DOI":"10.1152\/ajpheart.00774.2018","volume":"317","author":"EJ Tsiklidis","year":"2019","unstructured":"Tsiklidis, E. J., Sinno, T. & Diamond, S. L. Coagulopathy implications using a multiscale model of traumatic bleeding matching macro- and microcirculation. Am. J. Physiol.-Heart Circ. Physiol. 317, H73\u2013H86 (2019).","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"50190_CR5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.bpj.2021.01.022","volume":"120","author":"AV Belyaev","year":"2021","unstructured":"Belyaev, A. V. Intradimer forces and their implication for conformations of von Willebrand factor multimers. Biophys. J . 120, 899\u2013911 (2021).","journal-title":"Biophys. J ."},{"key":"50190_CR6","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1111\/jth.15096","volume":"18","author":"X Xu","year":"2020","unstructured":"Xu, X., Kozar, R., Zhang, J. & Dong, J. Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy. J. Thromb. Haemost. 18, 3154\u20133162 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"50190_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00702-012-0784-0","volume":"119","author":"B Mollenhauer","year":"2012","unstructured":"Mollenhauer, B. et al. \u03b1-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system. J Neural Transm 119, 739\u2013746 (2012).","journal-title":"J Neural Transm"},{"key":"50190_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41531-025-01091-z","volume":"11","author":"J-Y Jeong","year":"2025","unstructured":"Jeong, J.-Y. et al. Elevated plasma levels of alpha-synuclein are dispensable for Parkinson\u2019s disease pathology. npj Parkinsons Dis. 11, 228 (2025).","journal-title":"npj Parkinsons Dis."},{"key":"50190_CR9","doi-asserted-by":"publisher","first-page":"9880","DOI":"10.1038\/s41598-022-12886-y","volume":"12","author":"L Acquasaliente","year":"2022","unstructured":"Acquasaliente, L. et al. Exogenous human \u03b1-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting \u03b1-thrombin-induced platelet activation. Sci. Rep. 12, 9880 (2022).","journal-title":"Sci. Rep."},{"key":"50190_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2025.107321","volume":"133","author":"K Dimoula","year":"2025","unstructured":"Dimoula, K., Papagiannakis, N., Maniati, M., Stefanis, L. & Emmanouilidou, E. Aggregated \u03b1-synuclein in erythrocytes as a potential biomarker for idiopathic Parkinson\u2019s Disease. Parkinsonism Relat. Disord. 133, 107321 (2025).","journal-title":"Parkinsonism Relat. Disord."},{"key":"50190_CR11","doi-asserted-by":"publisher","first-page":"31837","DOI":"10.1038\/s41598-025-11979-8","volume":"15","author":"RN Coyle","year":"2025","unstructured":"Coyle, R. N. et al. Alpha-synuclein is increased in erythrocytes in parkinson\u2019s disease cases. Sci. Rep. 15, 31837 (2025).","journal-title":"Sci. Rep."},{"key":"50190_CR12","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3389\/fneur.2019.01388","volume":"10","author":"C-W Chang","year":"2020","unstructured":"Chang, C.-W., Yang, S.-Y., Yang, C.-C., Chang, C.-W. & Wu, Y.-R. Plasma and serum alpha-synuclein as a biomarker of diagnosis in patients with Parkinson\u2019s disease. Front. Neurol. 10, 1388 (2020).","journal-title":"Front. Neurol."},{"key":"50190_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","volume":"8","author":"P Magalh\u00e3es","year":"2022","unstructured":"Magalh\u00e3es, P. & Lashuel, H. A. Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies. npj Parkinsons Dis. 8, 93 (2022).","journal-title":"npj Parkinsons Dis."},{"key":"50190_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2217\/bmm.15.107","volume":"10","author":"L Parnetti","year":"2016","unstructured":"Parnetti, L., Cicognola, C., Eusebi, P. & Chiasserini, D. Value of cerebrospinal fluid \u03b1-synuclein species as biomarker in Parkinson\u2019S diagnosis and prognosis. Biomark. Med. 10, 35\u201349 (2016).","journal-title":"Biomark. Med."},{"key":"50190_CR15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2322572121","volume":"121","author":"E Axell","year":"2024","unstructured":"Axell, E. et al. The role of shear forces in primary and secondary nucleation of amyloid fibrils. Proc. Natl. Acad. Sci. U.S.A. 121, e2322572121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"50190_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2020.106520","volume":"269","author":"JD Camino","year":"2021","unstructured":"Camino, J. D., Gracia, P. & Cremades, N. The role of water in the primary nucleation of protein amyloid aggregation. Biophys. Chem. 269, 106520 (2021).","journal-title":"Biophys. Chem."},{"key":"50190_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.562241","volume":"8","author":"M Kiechle","year":"2020","unstructured":"Kiechle, M., Grozdanov, V. & Danzer, K. M. The role of lipids in the initiation of \u03b1-synuclein misfolding. Front. Cell Dev. Biol. 8, 562241 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"50190_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2024.105760","volume":"177","author":"S Negi","year":"2024","unstructured":"Negi, S., Khurana, N. & Duggal, N. The misfolding mystery: \u03b1-synuclein and the pathogenesis of Parkinson\u2019s disease. Neurochem. Int. 177, 105760 (2024).","journal-title":"Neurochem. Int."},{"key":"50190_CR19","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1021\/ja412105t","volume":"136","author":"S Campioni","year":"2014","unstructured":"Campioni, S. et al. The presence of an air-water interface affects formation and elongation of \u03b1-synuclein fibrils. J. Am. Chem. Soc. 136, 2866\u20132875 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"50190_CR20","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1039\/D4CC01591F","volume":"60","author":"W Han","year":"2024","unstructured":"Han, W., Wei, M., Xu, F. & Niu, Z. Aggregation and phase separation of \u03b1-synuclein in Parkinson\u2019s disease. Chem. Commun. 60, 6581\u20136590 (2024).","journal-title":"Chem. Commun."},{"key":"50190_CR21","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1039\/D3SC05661A","volume":"15","author":"AJ Dear","year":"2024","unstructured":"Dear, A. J. et al. Molecular mechanism of \u03b1-synuclein aggregation on lipid membranes revealed. Chem. Sci. 15, 7229\u20137242 (2024).","journal-title":"Chem. Sci."},{"key":"50190_CR22","doi-asserted-by":"publisher","first-page":"1494218","DOI":"10.3389\/fnmol.2024.1494218","volume":"17","author":"ED Ruiz-Ortega","year":"2024","unstructured":"Ruiz-Ortega, E. D., Wilkaniec, A. & Adamczyk, A. Liquid\u2013liquid phase separation and conformational strains of \u03b1-synuclein: implications for Parkinson\u2019s disease pathogenesis. Front. Mol. Neurosci. 17, 1494218 (2024).","journal-title":"Front. Mol. Neurosci."},{"key":"50190_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s44328-025-00027-0","volume":"2","author":"Y Goto","year":"2025","unstructured":"Goto, Y. et al. Peristaltic pump-triggered amyloid formation suggests shear stresses are in vivo risks for amyloid nucleation. npj Biosens. 2, 4 (2025).","journal-title":"npj Biosens."},{"key":"50190_CR24","doi-asserted-by":"publisher","DOI":"10.1115\/1.4046330","volume":"142","author":"H Hosseini","year":"2020","unstructured":"Hosseini, H. et al. Probing flow-induced biomolecular interactions with micro-extensional rheology: Tau protein aggregation. J. Biomech. Eng. 142, 034501 (2020).","journal-title":"J. Biomech. Eng."},{"key":"50190_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3233\/JAD-201025","volume":"79","author":"CN Trumbore","year":"2021","unstructured":"Trumbore, C. N. Shear-induced amyloid aggregation in the brain: V. Are Alzheimer\u2019s and other amyloid diseases initiated in the lower brain and brainstem by cerebrospinal fluid flow stresses?. J. Alzheimer\u2019s Dis. 79, 979\u20131002 (2021).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"50190_CR26","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1529\/biophysj.106.089367","volume":"91","author":"J Jaspe","year":"2006","unstructured":"Jaspe, J. & Hagen, S. J. Do protein molecules unfold in a simple shear flow?. Biophys. J . 91, 3415\u20133424 (2006).","journal-title":"Biophys. J ."},{"key":"50190_CR27","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevLett.97.138101","volume":"97","author":"A Alexander-Katz","year":"2006","unstructured":"Alexander-Katz, A., Schneider, M. F., Schneider, S. W., Wixforth, A. & Netz, R. R. Shear-flow-induced unfolding of polymeric globules. Phys. Rev. Lett. 97, 138101 (2006).","journal-title":"Phys. Rev. Lett."},{"key":"50190_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4070\/kcj.2011.41.6.287","volume":"41","author":"Y-I Cho","year":"2011","unstructured":"Cho, Y.-I. & Cho, D. J. Hemorheology and microvascular disorders. Korean Circ. J. 41, 287 (2011).","journal-title":"Korean Circ. J."},{"key":"50190_CR29","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/s10439-021-02845-5","volume":"49","author":"M Zhussupbekov","year":"2021","unstructured":"Zhussupbekov, M., M\u00e9ndez Rojano, R., Wu, W.-T., Massoudi, M. & Antaki, J. F. A continuum model for the unfolding of von Willebrand Factor. Ann. Biomed. Eng. 49, 2646\u20132658 (2021).","journal-title":"Ann. Biomed. Eng."},{"key":"50190_CR30","doi-asserted-by":"publisher","first-page":"7899","DOI":"10.1073\/pnas.0608422104","volume":"104","author":"SW Schneider","year":"2007","unstructured":"Schneider, S. W. et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc. Natl. Acad. Sci. U.S.A. 104, 7899\u20137903 (2007).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"50190_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jvs.2018.04.036","volume":"69","author":"N Hariri","year":"2019","unstructured":"Hariri, N., Russell, T., Kasper, G. & Lurie, F. Shear rate is a better marker of symptomatic ischemic cerebrovascular events than velocity or diameter in severe carotid artery stenosis. J. Vasc. Surg. 69, 448\u2013452 (2019).","journal-title":"J. Vasc. Surg."},{"key":"50190_CR32","doi-asserted-by":"crossref","unstructured":"Thomas, R. et al. Plasma von Willebrand Factor is elevated hyperacutely after mild traumatic brain injury. Neurotrauma Rep. 4, neur.2023.0044 (2023).","DOI":"10.1089\/neur.2023.0044"},{"key":"50190_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fneur.2019.00409","volume":"10","author":"N Ziliotto","year":"2019","unstructured":"Ziliotto, N., Bernardi, F., Jakimovski, D. & Zivadinov, R. Coagulation pathways in neurological diseases: Multiple sclerosis. Front. Neurol. 10, 409 (2019).","journal-title":"Front. Neurol."},{"key":"50190_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.05.050","author":"Z Huang","year":"2025","unstructured":"Huang, Z. et al. Fibrinogen exacerbates \u03b1-synuclein aggregation and mitochondrial dysfunction via alpha5beta3 integrin in Parkinson\u2019s disease. J. Adv. Res. https:\/\/doi.org\/10.1016\/j.jare.2025.05.050 (2025).","journal-title":"J. Adv. Res."},{"key":"50190_CR35","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1212\/WNL.0b013e3182904d43","volume":"80","author":"S Mondello","year":"2013","unstructured":"Mondello, S., Buki, A., Italiano, D. & Jeromin, A. \u03b1-Synuclein in CSF of patients with severe traumatic brain injury. Neurology 80, 1662\u20131668 (2013).","journal-title":"Neurology"},{"key":"50190_CR36","doi-asserted-by":"publisher","first-page":"9197","DOI":"10.3390\/ijms25179197","volume":"25","author":"D Krawczuk","year":"2024","unstructured":"Krawczuk, D., Groblewska, M., Mroczko, J., Winkel, I. & Mroczko, B. The role of \u03b1-synuclein in etiology of neurodegenerative diseases. IJMS 25, 9197 (2024).","journal-title":"IJMS"},{"key":"50190_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"Y-T Sui","year":"2014","unstructured":"Sui, Y.-T., Bullock, K. M., Erickson, M. A., Zhang, J. & Banks, W. A. Alpha synuclein is transported into and out of the brain by the blood\u2013brain barrier. Peptides 62, 197\u2013202 (2014).","journal-title":"Peptides"},{"key":"50190_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C","volume":"21","author":"JC McDonald","year":"2000","unstructured":"McDonald, J. C. et al. Fabrication of microfluidic systems in poly(dimethylsiloxane). Electrophoresis 21, 27\u201340 (2000).","journal-title":"Electrophoresis"},{"key":"50190_CR39","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1177\/002215540004800906","volume":"48","author":"SD Styren","year":"2000","unstructured":"Styren, S. D., Hamilton, R. L., Styren, G. C. & Klunk, W. E. X-34, A fluorescent derivative of Congo red: A novel histochemical stain for Alzheimer\u2019s disease pathology. J. Histochem. Cytochem. 48, 1223\u20131232 (2000).","journal-title":"J. Histochem. Cytochem."},{"key":"50190_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.tracli.2025.09.004","author":"J Deb","year":"2025","unstructured":"Deb, J. et al. Cryoprecipitate utilization review in light of recent guidelines: A single-center prospective analysis of haemato-oncology patients. Transfus. Clin. Biologique https:\/\/doi.org\/10.1016\/j.tracli.2025.09.004 (2025).","journal-title":"Transfus. Clin. Biologique"},{"key":"50190_CR41","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/ijlh.13445","volume":"43","author":"S Jo","year":"2021","unstructured":"Jo, S., Kim, I. & Kim, H. Potential misdiagnosis of von Willebrand disease caused by insufficient mixing after thawing frozen plasma. Int. J. Lab Hematol. 43, 831\u2013836 (2021).","journal-title":"Int. J. Lab Hematol."},{"key":"50190_CR42","doi-asserted-by":"publisher","first-page":"456","DOI":"10.21037\/atm.2018.11.24","volume":"6","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y., Feng, G. & Feng, L. Effects of pre-analytical storage time, temperature, and freeze-thaw times on coagulation factors activities in citrate-anticoagulated plasma. Ann. Transl. Med 6, 456\u2013456 (2018).","journal-title":"Ann. Transl. Med"},{"key":"50190_CR43","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/tme.13061","volume":"34","author":"J McCullagh","year":"2024","unstructured":"McCullagh, J. et al. Every minute counts: A comparison of thawing times and haemostatic quality of plasma thawed at 37\u00b0C and 45\u00b0C using four different methods. Transfus. Med. 34, 304\u2013310 (2024).","journal-title":"Transfus. Med."},{"key":"50190_CR44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P. et al. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14, 176 (2023).","journal-title":"Cell Death Dis"},{"key":"50190_CR45","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.3390\/genes12071006","volume":"12","author":"JO Day","year":"2021","unstructured":"Day, J. O. & Mullin, S. The genetics of Parkinson\u2019s disease and implications for clinical practice. Genes 12, 1006 (2021).","journal-title":"Genes"},{"key":"50190_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.14802\/jmd.24075","volume":"17","author":"T Hatano","year":"2024","unstructured":"Hatano, T., Okuzumi, A., Matsumoto, G., Tsunemi, T. & Hattori, N. \u03b1-Synuclein: A promising biomarker for Parkinson\u2019s disease and related disorders. JMD 17, 127\u2013137 (2024).","journal-title":"JMD"},{"key":"50190_CR47","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2377-8-6","volume":"8","author":"DB Hancock","year":"2008","unstructured":"Hancock, D. B. et al. Pesticide exposure and risk of Parkinson\u2019s disease: A family-based case-control study. BMC Neurol. 8, 6 (2008).","journal-title":"BMC Neurol."},{"key":"50190_CR48","doi-asserted-by":"publisher","unstructured":"Da Silva, P. H. P. et al. Revisiting the Association of Pesticide Exposure and Parkinson\u2019s Disease: Systematic Review and Meta\u2010Analysis. Environmental Toxicology tox.70041. https:\/\/doi.org\/10.1002\/tox.70041 (2026).","DOI":"10.1002\/tox.70041"},{"key":"50190_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.neuroscience.2025.08.060","volume":"585","author":"H Singh","year":"2025","unstructured":"Singh, H., Kumari, S. & Taliyan, R. Epigenetic mechanisms linking environmental exposure to Parkinson\u2019s disease: A comprehensive review. Neuroscience 585, 367\u2013380 (2025).","journal-title":"Neuroscience"},{"key":"50190_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijbiomac.2016.10.021","volume":"100","author":"D Ghosh","year":"2017","unstructured":"Ghosh, D., Mehra, S., Sahay, S., Singh, P. K. & Maji, S. K. \u03b1-synuclein aggregation and its modulation. Int. J. Biol. Macromol. 100, 37\u201354 (2017).","journal-title":"Int. J. Biol. Macromol."},{"key":"50190_CR51","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/jnen\/nly024","volume":"77","author":"O Scudamore","year":"2018","unstructured":"Scudamore, O. & Ciossek, T. Increased oxidative stress exacerbates \u03b1-synuclein aggregation in vivo. J. Neuropathol. Exp. Neurol. 77, 443\u2013453 (2018).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"50190_CR52","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00018-022-04240-2","volume":"79","author":"GK Tofaris","year":"2022","unstructured":"Tofaris, G. K. Initiation and progression of \u03b1-synuclein pathology in Parkinson\u2019s disease. Cell. Mol. Life Sci. 79, 210 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"50190_CR53","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin, D. et al. Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat Commun 13, 5512 (2022).","journal-title":"Nat Commun"},{"key":"50190_CR54","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.4103\/1673-5374.371345","volume":"18","author":"A Bigi","year":"2023","unstructured":"Bigi, A., Cascella, R. & Cecchi, C. \u03b1-Synuclein oligomers and fibrils: partners in crime in synucleinopathies. Neural Regen. Res. 18, 2332\u20132342 (2023).","journal-title":"Neural Regen. Res."},{"key":"50190_CR55","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1038\/s41467-021-21937-3","volume":"12","author":"R Cascella","year":"2021","unstructured":"Cascella, R. et al. The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells. Nat. Commun. 12, 1814 (2021).","journal-title":"Nat. Commun."},{"key":"50190_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105086","volume":"146","author":"ST Kumar","year":"2020","unstructured":"Kumar, S. T. et al. How specific are the conformation-specific \u03b1-synuclein antibodies? Characterization and validation of 16 \u03b1-synuclein conformation-specific antibodies using well-characterized preparations of \u03b1-synuclein monomers, fibrils and oligomers with distinct structures and morphology. Neurobiol. Dis. 146, 105086 (2020).","journal-title":"Neurobiol. Dis."},{"key":"50190_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41531-024-00841-9","volume":"10","author":"NM Jensen","year":"2024","unstructured":"Jensen, N. M. et al. MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity. npj Parkinsons Dis. 10, 227 (2024).","journal-title":"npj Parkinsons Dis."},{"key":"50190_CR58","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13024-024-00782-0","volume":"19","author":"S Greally","year":"2024","unstructured":"Greally, S. et al. Dementia with lewy bodies patients with high tau levels display unique proteome profiles. Mol. Neurodegener. 19, 98 (2024).","journal-title":"Mol. Neurodegener."},{"key":"50190_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196056","volume":"13","author":"LB Lassen","year":"2018","unstructured":"Lassen, L. B. et al. ELISA method to detect \u03b1-synuclein oligomers in cell and animal models. PLoS ONE 13, e0196056 (2018).","journal-title":"PLoS ONE"},{"key":"50190_CR60","doi-asserted-by":"publisher","first-page":"9016","DOI":"10.1074\/jbc.REV119.007500","volume":"294","author":"CL Ugalde","year":"2019","unstructured":"Ugalde, C. L., Lawson, V. A., Finkelstein, D. I. & Hill, A. F. The role of lipids in \u03b1-synuclein misfolding and neurotoxicity. J. Biol. Chem. 294, 9016\u20139028 (2019).","journal-title":"J. Biol. Chem."},{"key":"50190_CR61","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood.2023019749","volume":"142","author":"DW Chung","year":"2023","unstructured":"Chung, D. W. et al. Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand Factor self-association. Blood 142, 1156\u20131166 (2023).","journal-title":"Blood"},{"key":"50190_CR62","doi-asserted-by":"publisher","first-page":"1373266","DOI":"10.3389\/fneur.2024.1373266","volume":"15","author":"A Mc Mahon","year":"2024","unstructured":"Mc Mahon, A. et al. Extracellular vesicles in disorders of hemostasis following traumatic brain injury. Front. Neurol. 15, 1373266 (2024).","journal-title":"Front. Neurol."},{"key":"50190_CR63","doi-asserted-by":"publisher","first-page":"22313","DOI":"10.18632\/aging.103675","volume":"12","author":"H Zeng","year":"2020","unstructured":"Zeng, H., Liu, N., Liu, X.-X., Yang, Y.-Y. & Zhou, M.-W. \u03b1-Synuclein in traumatic and vascular diseases of the central nervous system. Aging 12, 22313\u201322334 (2020).","journal-title":"Aging"},{"key":"50190_CR64","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1182\/blood-2018-03-841932","volume":"132","author":"Y Wu","year":"2018","unstructured":"Wu, Y. et al. von Willebrand factor enhances microvesicle-induced vascular leakage and coagulopathy in mice with traumatic brain injury. Blood 132, 1075\u20131084 (2018).","journal-title":"Blood"},{"key":"50190_CR65","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/ana.24396","volume":"77","author":"RC Gardner","year":"2015","unstructured":"Gardner, R. C. et al. Traumatic brain injury in later life increases risk for P arkinson disease. Ann. Neurol. 77, 987\u2013995 (2015).","journal-title":"Ann. Neurol."},{"key":"50190_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195765","volume":"13","author":"JM Roberts","year":"2018","unstructured":"Roberts, J. M., Maniskas, M. E. & Bix, G. J. Bilateral carotid artery stenosis causes unexpected early changes in brain extracellular matrix and blood-brain barrier integrity in mice. PLoS ONE 13, e0195765 (2018).","journal-title":"PLoS ONE"},{"key":"50190_CR67","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12974-024-03209-1","volume":"21","author":"L Lin","year":"2024","unstructured":"Lin, L. et al. Carotid artery vascular stenosis causes the blood-CSF barrier damage and neuroinflammation. J. Neuroinflamm. 21, 220 (2024).","journal-title":"J. Neuroinflamm."},{"key":"50190_CR68","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1161\/STROKEAHA.125.052265","volume":"56","author":"TA Bogale","year":"2025","unstructured":"Bogale, T. A. et al. Experimental ischemic stroke-induced alpha-synuclein pathology enhances endothelial inflammatory response and impairs angiogenesis. Stroke 56, 3424\u20133437 (2025).","journal-title":"Stroke"},{"key":"50190_CR69","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1523\/JNEUROSCI.1241-16.2016","volume":"36","author":"T Kim","year":"2016","unstructured":"Kim, T. et al. Poststroke induction of -synuclein mediates ischemic brain damage. J. Neurosci. 36, 7055\u20137065 (2016).","journal-title":"J. Neurosci."},{"key":"50190_CR70","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s41983-024-00837-5","volume":"60","author":"AS Sabbah","year":"2024","unstructured":"Sabbah, A. S. et al. Role of Von Willebrand Factor level as a biomarker in acute ischemic stroke. Egypt. J. Neurol. Psychiatry Neurosurg. 60, 63 (2024).","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"50190_CR71","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1538-7836.2010.04134.x","volume":"9","author":"E Hanson","year":"2011","unstructured":"Hanson, E. et al. Plasma levels of von Willebrand Factor in the etiologic subtypes of ischemic stroke. J. Thromb. Haemost. 9, 275\u2013281 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"50190_CR72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-024-02696-z","volume":"147","author":"Y-C Wu","year":"2024","unstructured":"Wu, Y.-C. et al. The contribution of \u03b2-amyloid, Tau and \u03b1-synuclein to blood\u2013brain barrier damage in neurodegenerative disorders. Acta Neuropathol. 147, 39 (2024).","journal-title":"Acta Neuropathol."},{"key":"50190_CR73","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.25564","volume":"86","author":"BR Kummer","year":"2019","unstructured":"Kummer, B. R. et al. Associations between cerebrovascular risk factors and parkinson disease. Ann. Neurol. 86, 572\u2013581 (2019).","journal-title":"Ann. Neurol."},{"key":"50190_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16194","volume":"31","author":"HL Choi","year":"2024","unstructured":"Choi, H. L. et al. Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea. Eur. J. Neurol. 31, e16194 (2024).","journal-title":"Eur. J. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50190-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50190-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50190-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:02:08Z","timestamp":1782086528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-50190-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["50190"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-50190-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19218"}}